AI
AdvisorShares Investments Portfolio holdings
AUM
$555M
This Quarter Return
+1.97%
1 Year Return
+19.49%
3 Year Return
+67.68%
5 Year Return
+78.74%
10 Year Return
–
AUM
$518M
AUM Growth
+$518M
(-0.68%)
Cap. Flow
-$8.56M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
46.99%
Holding
345
New
77
Increased
74
Reduced
81
Closed
81
Top Buys
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$56.6M |
| 2 |
iShares Morningstar Mid-Cap Growth ETF
IMCG
|
$41.3M |
| 3 |
iShares Morningstar US Equity ETF
ILCB
|
$10.9M |
| 4 |
Adobe
ADBE
|
$7.07M |
| 5 |
Mueller Industries
MLI
|
$7.03M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$56.7M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$51.7M |
| 3 |
Aflac
AFL
|
$8.69M |
| 4 |
DRUG
Bright Minds Biosciences
DRUG
|
$6.46M |
| 5 |
Hershey
HSY
|
$6.19M |
Sector Composition
| 1 | Technology | 11.83% |
| 2 | Healthcare | 10.45% |
| 3 | Consumer Discretionary | 9.3% |
| 4 | Industrials | 8.6% |
| 5 | Financials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
201
DELISTED
Sage Therapeutics
SAGE
| $260K | 0.05% |
47,800
+24,470
| +105% | +$133K |
|
202
Boston Beer
SAM
$2.38B
| $256K | 0.05% |
854
| – | – |
|
|
QNTM
203
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
QNTM
$59.9M
| $254K | 0.05% |
69,078
+42,845
| +163% | +$158K |
|
204
GH Research
GHRS
$870M
| $252K | 0.05% |
36,011
+4,806
| +15% | +$33.6K |
|
|
CMPS
205
Compass Pathways
CMPS
$452M
| $252K | 0.05% |
66,602
+22,720
| +52% | +$85.9K |
|
|
CGC
206
Canopy Growth
CGC
$437M
| $251K | 0.05% |
91,462
+540
| +0.6% | +$1.48K |
|
207
Skye Bioscience
SKYE
$104M
| $250K | 0.05% |
88,391
-26,609
| -23% | -$75.3K |
|
|
IMCC
208
IM Cannabis
IMCC
$10.7M
| $247K | 0.05% |
104,075
+615
| +0.6% | +$1.46K |
|
209
Dutch Bros
BROS
$9.1B
| $244K | 0.05% |
4,652
+594
| +15% | +$31.1K |
|
210
Target Hospitality
TH
$878M
| $241K | 0.05% |
24,889
+3,000
| +14% | +$29K |
|
211
Clearmind Medicine
CMND
$5.43M
| $232K | 0.04% |
167,856
-2,785
| -2% | -$3.84K |
|
212
Norwegian Cruise Line
NCLH
$11.5B
| $232K | 0.04% |
9,000
-1,000
| -10% | -$25.7K |
|
213
Royal Caribbean
RCL
$96.4B
| $231K | 0.04% |
1,000
-100
| -9% | -$23.1K |
|
214
Carnival Corp
CCL
$42.5B
| $224K | 0.04% |
9,000
+2,000
| +29% | +$49.8K |
|
215
Enveric Biosciences
ENVB
$3.41M
| $215K | 0.04% |
39,990
+15,520
| +63% | +$83.4K |
|
216
Travelzoo
TZOO
$102M
| $203K | 0.04% |
+10,200
| New | +$203K |
|
217
Viking Holdings
VIK
$27.7B
| $194K | 0.04% |
+4,400
| New | +$194K |
|
218
Atour Lifestyle Holdings
ATAT
$5.39B
| $188K | 0.04% |
+7,000
| New | +$188K |
|
219
Yum China
YUMC
$16.3B
| $186K | 0.04% |
3,861
+161
| +4% | +$7.76K |
|
220
Expedia Group
EXPE
$26.3B
| $180K | 0.03% |
967
-150
| -13% | -$27.9K |
|
221
InMed Pharmaceuticals
INM
$4.22M
| $177K | 0.03% |
38,460
+1,795
| +5% | +$8.28K |
|
|
INCR
222
Intercure
INCR
$87.8M
| $173K | 0.03% |
108,044
+630
| +0.6% | +$1.01K |
|
223
US Foods
USFD
$17.4B
| $169K | 0.03% |
2,509
+105
| +4% | +$7.08K |
|
224
Performance Food Group
PFGC
$16.2B
| $159K | 0.03% |
+1,879
| New | +$159K |
|
225
Pebblebrook Hotel Trust
PEB
$1.37B
| $159K | 0.03% |
+11,700
| New | +$159K |
|